Browse > Article

Two cases of Chryseobacterium meningosepticum infection in a neonatal intensive care unit  

Yoon, Hye Sun (Department of Pediatrics, School of Medicine, Eulji University)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.7, 2007 , pp. 698-701 More about this Journal
Abstract
We report on two premature infants who developed nosocomial infection caused by Chryseobacterium meningosepticum in a neonatal intensive care unit (NICU). One premature infant developed sepsis, meningitis, and hydrocephalus, and was treated successfully with ciprofloxacin plus trimethoprim-sulfamethoxazole combination therapy for 4 weeks and with a ventriculoperitoneal shunt. The other premature infant, who was in a chronically debilitated state, had infection that had colonized only in the respiratory tract but had no clinical signs for 66 days. Extensive environmental surveillance demonstrated that the suction bottle apparatus was the source of infection. We prevented the spread of infection by closing the NICU temporarily, isolating the patients early in their infection, and eradicating the source of infection source.
Keywords
Chryseobacterium meningosepticum; Ciprofloxacin; Neonatal intensive care unit;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chiu CH, Waddingdon M, Hsieh WS, Greenberg D, Schreckenberger PC, Carnahan AM. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan. Emerg Infect Dis 2000;6:481-6   DOI   ScienceOn
2 Gungor S, Ozen M, Akinci A, Durmaz R. A Chryseobacterium meningosepticum outbreak in a neonatal ward. Infect Control Hosp Epidemiol 2003;24:613-7   DOI   ScienceOn
3 Hoque SN, Graham J, Kaufmann ME, Tabaqchali S. Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infection 2001;47:188-92   DOI   ScienceOn
4 Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Reports of 6 cases and literature review. Medicine 1997;76:30-41   DOI   ScienceOn
5 Di Pentima MC, Mason EO Jr, Kaplan SL. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin Infect Dis 1998;26:1169-76   DOI   ScienceOn
6 Lin PY, Chu C, Su LH, Huang CT, Chang WY, Chiu CH. Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients. J Clin Microbiol 2004;42:3353-5   DOI   ScienceOn
7 Kubin R. Safety and efficacy of ciprofloxacin in paediaric patients-review. Infection 1993;21:413-21   DOI
8 van den Oever HL, Versteegh FG, Thewessen EA, van den Anker JN, Mouton JW, Neijens HJ. Ciprofloxacin in preterm neonates: case report and review of the literature. Eur J Pediatr 1998;157:843-5   DOI
9 Tekerekoglu MS, Durmaz R, Ayan M, Cizmeci Z, Akinci A. Analysis of an outbreak due to Chryseobacterium meningosepticum in a neonatal intensive care unit. New Microbiol 2003;26:57-63
10 Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp:report from th SENTRY antimicrobial surveillance program (1997-2001). J Clin Microbiol 2004;42:445-8   DOI   ScienceOn
11 Powell DA, Marcon MJ. Flavobacteriaceae. In: Long SS editor. Principles and practice of pediatric infectious diseases. 2nd ed. Oxford, Churchill Livingstone 2003:851-2